|
|
 |
|
Viewing report
|
|
|
|
Drug Delivery Systems: US Market Outlook, Advances for Pharma, Biotech & Medical Devices
Takeda Pacific, Sep 2006, Pages: 163
This research study is about drug delivery systems. It provides readers with relevant information, insights and analysis. This important medical opportunity is assessed in terms of technical and business areas. The participating companies are mapped to show where they fit in the industry landscape. This study reviews the kinds of drug delivery systems that are being used by pharma, biotech or medical device companies.
The report discusses the broad range of drug delivery systems, the technical advances and the applications that drug makers might use. Key advances include orally dissolving tablets and filmstrips, needle- and needle-free injection systems, transdermal patches, transmucosal delivery, RNAi, drug-coated stents, PEG, nanotechnology, liposomes, monoclonal antibodies, gene delivery, and implants, which all contribute to the many ways that drugs or therapies can be delivered. Drug delivery systems are reviewed in terms of approaches used for delivering drugs targeting major diseases including cardiovascular, cancer, asthma, diabetes, and the central nervous system among others.
This market study shows that drug delivery technologies can help drug makers overcome some of their big challenges. The drug industry continues to see the commercial demise of major branded drugs that reach their patent expiration date. Billions of dollars in revenues are lost to generic drug makers each year. The technology can be used as part of a ‘line extension’ strategy to extend the commercial life of their profitable products. Drug delivery can help ‘rescue’ drug projects with technical challenges by using a customized delivery system.
This report discusses the above topics with interesting and useful findings. The study estimates that the US drug delivery market value might reach nearly $85 billion by 2010. The research includes over 235 key alliances and M&As through 2006. This study uses 29 figures and tables to illustrate the findings or trends. The profiles about companies important to the expanding drug delivery market include detailed information about their business and technical activities.
This report would benefit people with job titles including CEO, VPs, Director of Business Development, Research Directors, Entrepreneurs, Venture Capitalists, Investment Planners, Research Scientists, Consultants or Industry Analysts.
Customers who bought this item also bought
Transdermal Drug Delivery - Technologies, Markets, and Companies
Drug Delivery in Cancer - Technologies, Markets and Companies
Cardiovascular Drug Delivery - Technologies, Markets and Companies
Nanoparticle Drug Delivery Market Report
Drug Delivery: Active Transdermal Delivery Systems
Drug Delivery Technology - Revolutionizing Cancer Therapies
Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies
2006 US Market Advanced Drug Delivery Systems Probing the Route to Growth
Drug Delivery Technologies - Current Market Dynamics, Future Market Opportunities and Lifecycle Strategies
Injectable Drug Delivery
Drug Delivery Technology - Revolutionizing CNS Therapies
Innovation in Drug Delivery: The Future of Nanotechnology and Non-invasive Protein Delivery
|
|
|
|
